Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. Source @NEJM https://t.co/I6HljhuTfG https://t.co/GamYDgQfFD
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jun 2024 – Oct 2025Where it's discussed
-
News285 articles
-
X / Twitter182 posts
-
Blogs18 articles
-
Facebook8 posts
-
YouTube3 videos
-
Bluesky2 posts
-
Reddit2 posts
AI synopsis
What people are saying
Several discussions illustrate excitement over tirzepatide's potential benefits, with phrases like 'miracle drug' and 'game changer' highlighting enthusiasm for its application. For instance, comments referencing the reduction of the apnea-hypopnea index and weight loss, as well as the trial results, demonstrate a focused interest in exploring the drug's implications for treatment. The tone across many posts conveys optimism while using assertive language that emphasizes new therapeutic strategies.
The majority of posts exhibit a favorable view of tirzepatide's effectiveness, indicating moderate support for the publication's findings.
Posts show strong curiosity and relevance, reflecting readers' eagerness to understand the implications of the results.
While some posts display depth by discussing the trial results, others appear less engaged, suggesting a mixed level of discourse.
Users widely believe the publication and its findings could significantly influence treatment approaches for obstructive sleep apnea and obesity.
Abstract in brief
- Tirzepatide shows promise as a treatment for obstructive sleep apnea (OSA) in patients with obesity by reducing the apneahypopnea index (AHI), which measures breathing disruptions during sleep.
- In two phase 3 trials, adults with moderate to severe OSA were given either tirzepatide or a placebo for 52 weeks, demonstrating significant reductions in AHI and body weight compared to placebo.
- The results indicated that tirzepatide led to a greater improvement in sleep apnea symptoms and overall health markers, suggesting its potential as a therapeutic option for these conditions.
Top posts
Most liked on X and BlueskyIn the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of tirzepatide for the treatment of adults with obstructive sleep apnea and obesity. Full results of both trials and Plain Language Summary: https://t.co/sAyCiZkZLH https://t.co/mYjrYTTk2y
GLP-1-Agonisten, nächstes Kapitel: Ja, wenn eine effektive Gewichtsreduktion stattfindet, dann bessert sich auch das Schlaf-Apnoe-Syndrom. https://t.co/7eoRj5xXrR
excited to discuss new #nejm paper on tirzepatide for #sleep apnea with #ats journal club @atscommunity https://t.co/ubN2yGLwgZ
Tirzepatide-OSA (NEJM 2024)
Este tratamiento tiene el potencial de mejorar la calidad de vida de millones de personas. El paper se publicó en el New England Journal of Medicine y se lee acá: https://t.co/yaeMADF54H
All mentions
Current Advances in Cardiology Screening, Vitamins, and Sleep Apnea Treatment
This week, John Mandrola MD discusses screening for valvular heart disease, the efficacy of multivitamins, and the role of CPAP in preventing cardiovascular events in sleep apnea patients. The insights highlight recent…
Tirzepatide: A Promising Treatment for Obstructive Sleep Apnea
In a groundbreaking study led by Dr. Atul Malhotra, researchers at UCSD have found that tirzepatide, a diabetes drug, effectively treats obstructive sleep apnea in obese patients. The study showed significant reductions…
Um artigo em um minuto: Tirzepatida para tratamento de Síndrome da Apneia Obstrutiva do sono
RT @drsinghaditya03: Tirzepatide-OSA (NEJM 2024)
RT @drsinghaditya03: Tirzepatide-OSA (NEJM 2024)
RT @drsinghaditya03: Tirzepatide-OSA (NEJM 2024)
Tirzepatide-OSA (NEJM 2024)
睡眠時無呼吸症候群に対して、GLP1注射が効果を示したとNEJMに報告されました。 睡眠中の無呼吸の回数が大きく減少 「痩せる薬」が睡眠時無呼吸の治療薬になり得るかもしれません。 マスク治療に加えて、新しい選択肢として期待されています。 #睡眠時無呼吸 #マンジャロ https://t.co/s6wfaU8P4i
RT @AmbrizMau: En pacientes con obesidad y apnea obstructiva del sueño moderada-grave, TIRZEPATIDA redujo el índice apnea-hipopnea, peso co…
@Cernovich Monjouro / Zepbound (Tirzepatide) is a miracle drug made in America. Now approved for treating obstructive sleep apnea. https://t.co/bFvxalOOCR
Can weight loss alone resolve OSA? Dr. @mazirules reviews the SURMOUNT-OSA trial showing tirzepatide cut AHI by up to 58.7% and improved sleep quality—even in patients not using CPAP.
RT @EricTopol: @CharlieWiseCPA Malhotra, A. et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N. Engl. J. Med. h…
@CharlieWiseCPA Malhotra, A. et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N. Engl. J. Med. https://t.co/fTFvIhofEf NEJMoa2404881 (2024).
RT @gorka_orive: Se suceden los estudios que analizan el potencial de los fármacos agonistas del receptor GLP-1 en enfermedades como el Par…
9/
#ATS2025 Pearls: Clinical Year in Review on #Sleep medicine: 1. Tirzepatide for the treatment of obstructive sleep apnea and obesity: -This article reports the safety and efficacy of tirzepatide for the treatment of adults with #OSA and obesity based on the results of Two https://t.co/D4CxhJEUxU
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH Ed…
https://t.co/0fVTD4xZ0X
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine https://t.co/wPUSgWVxrQ
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH Ed…
Sleep Apnea & Zepbound (2 of 5) In recent randomized, double-blind, placebo-controlled studies of obese adults without type 2 diabetes, t Tirzepatide significantly helped patients with obstrucive sleep apnea (N Engl J Med 2024;391:1193-1205 DOI: 10.1056/NEJMoa2404881)
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity https://t.co/SXefp0fAXg
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity(NEJM) 閉塞性睡眠時無呼吸症候群および肥満症の治療薬としてのチルゼパチド(マンジャロ) https://t.co/O4Z8h6zNJx
RT @AMAREVA_Madrid: Comentario de @TGijonConde sobre Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. Estudio SURMO…
Comentario de @TGijonConde sobre Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. Estudio SURMOUNT-OSA https://t.co/Lhxtj1jjeO https://t.co/mI3q058sh1
RT @PubTrend: Trending on PubMed: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. https://t.co/5nRzKe9XcH
RT @AMAREVA_Madrid: Nuevo articulo comentado por @TGijonConde Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. Estudi…
Nuevo articulo comentado por @TGijonConde Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. Estudio SURMOUNT-OSA https://t.co/Lhxtj1jjeO https://t.co/uoKDz8ht4H
@usehex https://t.co/sZJfCbkFDr
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH Ed…
In patients with OSA and obesity, tirzepatide reduced the apnea-hypopnea index, weight, hypoxic burden, hsCRP concentration, and systolic blood pressure and improved sleep-related patient-reported outcomes. There may be no limit to what these wonder drugs. https://t.co/T9qhJwCNDC
NEJM 2024.Dec チルゼパチド(GIP/GLP-1受容体作動薬)は、中等度から重度の閉塞性睡眠時無呼吸症候群および肥満患者において、AHI、体重、低酸素負荷などを有意に改善する可能性 #SAS #NEJM https://t.co/tWotrWEiQN
マンジャロ使うくらいなら、コーラ飲むのやめて、お茶でも飲みな。 Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine https://t.co/h4WyVdFVrD
中等症から重症の閉塞性睡眠時無呼吸と肥満を合併する成人を対象とした2つの第3相二重盲検ランダム化比較試験において、GLP-1受容体作動薬であるチルゼパチドが、無呼吸低呼吸指数、体重、低酸素負荷を減少させ、睡眠関連の患者報告アウトカムを改善 https://t.co/mql5E4tXir
RT @KazemOsmanDO: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine https://t.co/EoRnc…
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine https://t.co/EoRncIvEiZ #obesity #health #weightloss #weightlossjourney #glp1 #Medicine
i guess it takes a while but nice to see basic and translational research eventually impacting patients - wow #ucsd @atscommunity #nhlbi https://t.co/8XyWRzjnZx; https://t.co/Py9tWPUq2P
تمت الموافقة على الدواء لعلاج الحالات المتوسطة إلى الشديدة من انقطاع النفس الانسدادي أثناء النوم لدى البالغين المصابين بالسمنة. تشمل العلاجات الشائعة لهذا الاضطراب: •أجهزة CPAP، •العمليات الجراحية، •بالإضافة إلى فقدان الوزن. https://t.co/i2Wm70Oocp
Is there anything it can’t do? Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2404881
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine https://t.co/6R7ZeNs4gq
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (NEJM) デュアルGIP/GLP-1受容体作動薬の対象範囲が睡眠障害分野にも... https://t.co/O4Z8h6zNJx
The Surmount-OSA trial Tirzepatide continues to demonstrate efficacy for metabolic syndrome related disorders. It reduced AHI in obstructive sleep apnea by over 20! https://t.co/Et60G9IJMZ
New treatments of OSAS with weight loss; Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity www.nejm.org/doi/full/10....
閉塞性睡眠時無呼吸症候群(OSA)および肥満を有する患者に対するチルゼパチド(GLP-1およびGIP受容体に作用する二重作動薬)の有効性と安全性を評価したもの。52週間の治療により、無呼吸低呼吸指数(AHI)を有意に改善し、睡眠関連アウトカムの向上を示した。https://t.co/Ue93E8kmj7
RT @drbennisahmed: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity tirzepatide reduced the AHI, body weight, hypoxic…
RT @drbennisahmed: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity tirzepatide reduced the AHI, body weight, hypoxic…
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity tirzepatide reduced the AHI, body weight, hypoxic burden, hsCRP concentration, and systolic blood pressure and improved sleep-related patient-reported outcomes https://t.co/jPKh5sa0bG
Tirzepatida en el SAOS y la obesidad https://t.co/zbaXIOeO0L PMID 38912654
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine https://t.co/4xXJdor6En
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity https://t.co/Qvobsk7309
RT @TSM_Humanist: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. Source @NEJM https://t.co/I6HljhuTfG https://t.co/…
Tirzepatide para el tratamiento de Apnea Obstructiva del Sueño y obesidad
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity #science #publication #research #publications https://t.co/9QTZ2Ogl2C
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity #science #publication #research #journal https://t.co/Aou4EFKebh
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine https://t.co/hGy4tsSQZ5
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine https://t.co/z3bTxb4OrB
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine https://t.co/LuItnc4rDL
RT @tipssovetorax: Exceso de adiposidad es importante factor de riesgo reversible en apnea obstructiva del sueño AOS y sus complicaciones.…
RT @tipssovetorax: Ensayos SURMOUNT-OSA de fase 3, multicéntricos, de 52 semanas en 9 países evaluaron eficacia y seguridad de la dosis máx…
RT @tipssovetorax: Apnea obstructiva del sueño es común y tiene importantes consecuencias médicas y económicas; más de 900 millones de pers…
RT @tipssovetorax: Exceso de adiposidad es importante factor de riesgo reversible en apnea obstructiva del sueño AOS y sus complicaciones.…
RT @tipssovetorax: Exceso de adiposidad es importante factor de riesgo reversible en apnea obstructiva del sueño AOS y sus complicaciones.…
Ensayos SURMOUNT-OSA de fase 3, multicéntricos, de 52 semanas en 9 países evaluaron eficacia y seguridad de la dosis máxima tolerada de tirzepatida semanal (10 mg o 15 mg) en adultos con apnea obstructiva del sueño de moderada a grave y obesidad 6 10.1056/NEJMoa2404881
Farmacoteraia dirigida a obesidad y sus efectos posteriores sobre apnea obstructiva del sueño, sus síntomas, presión arterial e inflamación sistémica de bajo grado facilitaria enfoque holístico que no se lograse con tratamientos mecánicos como PAP 5 10.1056/NEJMoa2404881
RT @tipssovetorax: En apnea obstructiva del sueño moderada a grave y obesidad, tirzepatide redujo el Indice Apnea Hipopnea IAH, el peso cor…
Exceso de adiposidad es importante factor de riesgo reversible en apnea obstructiva del sueño AOS y sus complicaciones. La reducción sustancial del peso en el tratamiento de AOS es bien reconocido, y guías clínicas la recomiendan en obesidad con AOS 4 DOI:10.1056/NEJMoa2404881
RT @tipssovetorax: El tratamiento de apnea obstructiva del sueño se basa en la presión positiva en las vías respiratorias (PAP) que mejora…
RT @tipssovetorax: El tratamiento de apnea obstructiva del sueño se basa en la presión positiva en las vías respiratorias (PAP) que mejora…
El tratamiento de apnea obstructiva del sueño se basa en la presión positiva en las vías respiratorias (PAP) que mejora el índice de apnea-hipopnea (IAH) y reduce los síntomas, pero su eficacia se afecta por la diferente adherencia a la terapia 3 DOI:10.1056/NEJMoa2404881
Apnea obstructiva del sueño es común y tiene importantes consecuencias médicas y económicas; más de 900 millones de personas se ven afectadas en el mundo, aproximadamente 40% con enfermedad moderada a grave 2 DOI: 10.1056/NEJMoa2404881
En apnea obstructiva del sueño moderada a grave y obesidad, tirzepatide redujo el Indice Apnea Hipopnea IAH, el peso corporal, la carga hipóxica, concentración de PCR us y la presión arterial sistólica y mejoró desenlaces informados relacionados al sueño 1 10.1056/NEJMoa2404881
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine https://t.co/KD3UR9tUv9
RT @NEJM: In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of tirzepatide for the treatment of adults with obst…
Tirzepatid obtruktif uyku apnesinde de etkili. Bir ilaç grubu herşeye mi iyi gelir? Cevap evet sanki... Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine https://t.co/8lmKQkmbSw
RT @TSM_Humanist: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. Source @NEJM https://t.co/I6HljhuTfG https://t.co/…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
Snacka om att slå in öppna dörrar https://t.co/JCeMT5xrM6
RT @NEJM: In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of tirzepatide for the treatment of adults with obst…
RT @NEJM: In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of tirzepatide for the treatment of adults with obst…
RT @NEJM: In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of tirzepatide for the treatment of adults with obst…
RT @NEJM: In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of tirzepatide for the treatment of adults with obst…
RT @NEJM: In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of tirzepatide for the treatment of adults with obst…
RT @NEJM: In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of tirzepatide for the treatment of adults with obst…
RT @NEJM: In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of tirzepatide for the treatment of adults with obst…
RT @NEJM: In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of tirzepatide for the treatment of adults with obst…
RT @NEJM: In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of tirzepatide for the treatment of adults with obst…
RT @NEJM: In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of tirzepatide for the treatment of adults with obst…
RT @NEJM: In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of tirzepatide for the treatment of adults with obst…
RT @NEJM: In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of tirzepatide for the treatment of adults with obst…
RT @NEJM: In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of tirzepatide for the treatment of adults with obst…
RT @NEJM: In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of tirzepatide for the treatment of adults with obst…
RT @NEJM: In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of tirzepatide for the treatment of adults with obst…
RT @NEJM: In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of tirzepatide for the treatment of adults with obst…
RT @NEJM: In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of tirzepatide for the treatment of adults with obst…
RT @NEJM: In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of tirzepatide for the treatment of adults with obst…
In the two SURMOUNT-OSA trials, researchers assessed the efficacy and safety of tirzepatide for the treatment of adults with obstructive sleep apnea and obesity. Full results of both trials and Plain Language Summary: https://t.co/sAyCiZkZLH https://t.co/mYjrYTTk2y
RT @TSM_Humanist: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. Source @NEJM https://t.co/I6HljhuTfG https://t.co/…
RT @TSM_Humanist: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. Source @NEJM https://t.co/I6HljhuTfG https://t.co/…
RT @TSM_Humanist: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. Source @NEJM https://t.co/I6HljhuTfG https://t.co/…
RT @TSM_Humanist: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. Source @NEJM https://t.co/I6HljhuTfG https://t.co/…
RT @TSM_Humanist: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. Source @NEJM https://t.co/I6HljhuTfG https://t.co/…
RT @TSM_Humanist: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. Source @NEJM https://t.co/I6HljhuTfG https://t.co/…
RT @TSM_Humanist: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. Source @NEJM https://t.co/I6HljhuTfG https://t.co/…
RT @TSM_Humanist: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. Source @NEJM https://t.co/I6HljhuTfG https://t.co/…
RT @TSM_Humanist: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. Source @NEJM https://t.co/I6HljhuTfG https://t.co/…
RT @TSM_Humanist: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. Source @NEJM https://t.co/I6HljhuTfG https://t.co/…
RT @TSM_Humanist: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. Source @NEJM https://t.co/I6HljhuTfG https://t.co/…
RT @TSM_Humanist: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. Source @NEJM https://t.co/I6HljhuTfG https://t.co/…
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. Source @NEJM https://t.co/I6HljhuTfG https://t.co/GamYDgQfFD
RT @ATSSRN: Hot off the press! SURMOUNT-OSA is finally here! Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New En…
GLP-1-Agonisten, nächstes Kapitel: Ja, wenn eine effektive Gewichtsreduktion stattfindet, dann bessert sich auch das Schlaf-Apnoe-Syndrom. https://t.co/7eoRj5xXrR
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine https://t.co/bI2D4khogy
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @VipsMDMEd: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine https://t.co/XlT8y9SI…
@ahosaku225 無呼吸症候群は 普通はCPAP(シーパップ)だけど ・肥満患者の場合は、 肥満改善薬チルゼパチド(マンジャロ)投与で改善! 当たり前と云えば当たり前の結果ですね~ https://t.co/EezR9W39wH
@doctorK1991 無呼吸症候群は 普通はCPAP(シーパップ)だけど ・肥満患者の場合は、 肥満改善薬チルゼパチド(マンジャロ)投与で改善! 当たり前と云えば当たり前の結果ですね~ https://t.co/EezR9W39wH
@DebaucheeAlone @Loverysnaradiko 無呼吸症候群は 普通はCPAP(シーパップ)だけど ・肥満患者の場合は、 肥満改善薬チルゼパチド(マンジャロ)投与で改善! 当たり前と云えば当たり前の結果ですね~ https://t.co/EezR9W39wH
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine https://t.co/kNrqsG9g3u
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine https://t.co/XlT8y9SIro
RT @AtulMalhotra13: excited to discuss new #nejm paper on tirzepatide for #sleep apnea with #ats journal club @atscommunity https://t.co/…
RT @AtulMalhotra13: excited to discuss new #nejm paper on tirzepatide for #sleep apnea with #ats journal club @atscommunity https://t.co/…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @AtulMalhotra13: Looking forward to #ats journal club tomorrow re: #nejm tirzepatide study https://t.co/Ei5T4F1yQf; https://t.co/ubN2yGL…
RT @AtulMalhotra13: Looking forward to #ats journal club tomorrow re: #nejm tirzepatide study https://t.co/Ei5T4F1yQf; https://t.co/ubN2yGL…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
Looking forward to #ats journal club tomorrow re: #nejm tirzepatide study https://t.co/Ei5T4F1yQf; https://t.co/ubN2yGLwgZ
excited to discuss new #nejm paper on tirzepatide for #sleep apnea with #ats journal club @atscommunity https://t.co/ubN2yGLwgZ
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @MedicinaSAM: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine Obvio, solo falta d…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @BertrandBio: $LLY Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine https://t.co/p…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine Obvio, solo falta demostrar su utilidad en pacientes con EPOC y sobrepeso.... https://t.co/5ToSpD5YS9
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @manut82004: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine https://t.co/29NskDE…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine https://t.co/29NskDEPSJ
RT @BertrandBio: $LLY Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine https://t.co/p…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine https://t.co/wiDLEY2U2r
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity https://t.co/oBY3zhNDLL #anesthesia #treatment #obstructive #sleep #apnea #obesity #sleepapnea #rest https://t.co/LUB16J4RRZ
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity https://t.co/XvMguHHrKj #anesthesia #treatment #obstructive #sleep #apnea #obesity #sleepapnea #rest https://t.co/ypo0huq0eO
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/DrEVEhmBRe Editorial: Entering a New Era in Sleep-Apnea Treatment https://t.co/JAbmcc4vxC https://t.co/pkKnqss6Ka
RT @NEJM: Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH E…
Tirzepatida para el tratamiento de la apnea obstructiva del sueño y la obesidad | New England Journal of Medicine https://t.co/ST5DoW9MlS
Tirzepatide, known for managing type 2 diabetes, could be the first effective drug therapy for obstructive sleep apnoea, according to @UCSanDiego in @NEJM: https://t.co/gNsEeOx46f https://t.co/bw6h1UOCKl
(NEJM) Tirzepatida para el tratamiento de la apnea obstructiva del sueño y la obesidad. https://t.co/vYUlUOje77
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity https://t.co/iC1Ywv9z33
RT @ObesitySeen: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity https://t.co/gP20BF41R7 como con la CB, la TZP consig…
RT @ObesitySeen: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity https://t.co/gP20BF41R7 como con la CB, la TZP consig…
RT @ObesitySeen: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity https://t.co/gP20BF41R7 como con la CB, la TZP consig…
RT @ObesitySeen: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity https://t.co/gP20BF41R7 como con la CB, la TZP consig…
RT @ObesitySeen: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity https://t.co/gP20BF41R7 como con la CB, la TZP consig…
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity https://t.co/gP20BF41R7 como con la CB, la TZP consigue mejoría de AOS con la consiguiente reduc. peso y mejoría TAS e inflamación: p. sin CPAP; IMC 39.1; IAH -20 ev/h; p con CPAP: IMC 38,7; -23,8 ev/h)
Trending on PubMed: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. https://t.co/5nRzKe9XcH
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity | New England Journal of Medicine https://t.co/GSkz1eF5bp
Tirzepatide for treatment of obstructive sleep apnea and obesity https://t.co/smZyfNQ7kA
評価されました。その結果、チルゼパチドが、人によっては一般的なOSA治療法である持続陽圧呼吸(CPAP)療法が不要になるレベルまで、OSAの重症度を測定するのに使われる重要な指標である睡眠中の呼吸中断回数を大幅に減少させることがわかりました。https://t.co/rE19KwffpM
RT @fedkukso: Este tratamiento tiene el potencial de mejorar la calidad de vida de millones de personas. El paper se publicó en el New Eng…
Este tratamiento tiene el potencial de mejorar la calidad de vida de millones de personas. El paper se publicó en el New England Journal of Medicine y se lee acá: https://t.co/yaeMADF54H